Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after ...

A research team was looking to make a new anti-inflammatory medication when they found some incredible side effects ...

Merck’s phase 3 HYPERION study of Winrevair meets primary endpoint in recently diagnosed adults with pulmonary arterial hypertension: Rahway, New Jersey Tuesday, June 24, 2025, ...

The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...

If Island Pharma’s drug keeps delivering, it could fast-track approval. And in a world with millions of dengue cases a year, ...

NKGen Biotech has activated two new trial sites in Canada and Florida, US, for the Phase I/IIa study of its cryopreserved expanded autologous natural killer (NK) cell therapy, troculeucel, in patients ...

CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...

Bayer and Tsinghua University (THU) announced that they have extended their research collaboration of 16 years by an additional three years, to further accelerate the translation of scientific ...

“ATR-258, a synthetic small molecule, has favourable pharmacokinetics and in Phase 1 clinical trials has been administered just once a day as a capsule, making it a straightforward, patient-friendly ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

Driven by a commitment to scientific excellence and public health, Emery Pharma continues to advance the field of impurity profiling—ensuring safer medicines and contributing to industry-wide efforts ...